European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

Christian Pristipino, Horst Sievert, Fabrizio D'Ascenzo, Jean Louis Mas, Bernhard Meier, Paolo Scacciatella, David Hildick-Smith, Fiorenzo Gaita, Danilo Toni, Paul Kyrle, John Thomson, Genevieve Derumeaux, Eustaquio Onorato, Dirk Sibbing, Peter Germonpré, Sergio Berti, Massimo Chessa, Francesco Bedogni, Dariusz Dudek, Marius HornungJose Zamorano, Pierluigi Omedè, Flavia Ballocca, Umberto Barbero, Francesca Giordana, Sebastiano Gili, Mario Iannaccone, Davide Capodannno, Marco Valgimigli, Robert Byrne, Teiji Akagi, John Carroll, Bharat Dalvi, Junbo Ge, Scott Kasner, Ina Michel-Behnke, Carlos Pedra, John Rhodes, Lars Søndergaard, Lars Thomassen, Giuseppe G.L. Biondi-Zoccai

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number of medical conditions; however, the subject remains controversial and no official statements have been published. This interdisciplinary paper, prepared with involvement of eight European scientific societies, aims to review the available trial evidence and to define the principles needed to guide decision making in patients with PFO. In order to guarantee a strict process, position statements were developed with the use of a modified grading of recommendations assessment, development, and evaluation (GRADE) methodology. A critical qualitative and quantitative evaluation of diagnostic and therapeutic procedures was performed, including assessment of the risk/benefit ratio. The level of evidence and the strength of the position statements of particular management options were weighed and graded according to predefined scales. Despite being based often on limited and non-randomised data, while waiting for more conclusive evidence, it was possible to conclude on a number of position statements regarding a rational general approach to PFO management and to specific considerations regarding left circulation thromboembolism. For some therapeutic aspects, it was possible to express stricter position statements based on randomised trials. This position paper provides the first largely shared, interdisciplinary approach for a rational PFO management based on the best available evidence.

Original languageEnglish
Pages (from-to)3182-3195
Number of pages14
JournalEuropean Heart Journal
Volume40
Issue number38
DOIs
Publication statusPublished - Oct 7 2019

Fingerprint

Patent Foramen Ovale
Thromboembolism
Decision Making
Odds Ratio
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pristipino, C., Sievert, H., D'Ascenzo, F., Louis Mas, J., Meier, B., Scacciatella, P., ... Biondi-Zoccai, G. G. L. (2019). European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. European Heart Journal, 40(38), 3182-3195. https://doi.org/10.1093/eurheartj/ehy649

European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. / Pristipino, Christian; Sievert, Horst; D'Ascenzo, Fabrizio; Louis Mas, Jean; Meier, Bernhard; Scacciatella, Paolo; Hildick-Smith, David; Gaita, Fiorenzo; Toni, Danilo; Kyrle, Paul; Thomson, John; Derumeaux, Genevieve; Onorato, Eustaquio; Sibbing, Dirk; Germonpré, Peter; Berti, Sergio; Chessa, Massimo; Bedogni, Francesco; Dudek, Dariusz; Hornung, Marius; Zamorano, Jose; Omedè, Pierluigi; Ballocca, Flavia; Barbero, Umberto; Giordana, Francesca; Gili, Sebastiano; Iannaccone, Mario; Capodannno, Davide; Valgimigli, Marco; Byrne, Robert; Akagi, Teiji; Carroll, John; Dalvi, Bharat; Ge, Junbo; Kasner, Scott; Michel-Behnke, Ina; Pedra, Carlos; Rhodes, John; Søndergaard, Lars; Thomassen, Lars; Biondi-Zoccai, Giuseppe G.L.

In: European Heart Journal, Vol. 40, No. 38, 07.10.2019, p. 3182-3195.

Research output: Contribution to journalArticle

Pristipino, C, Sievert, H, D'Ascenzo, F, Louis Mas, J, Meier, B, Scacciatella, P, Hildick-Smith, D, Gaita, F, Toni, D, Kyrle, P, Thomson, J, Derumeaux, G, Onorato, E, Sibbing, D, Germonpré, P, Berti, S, Chessa, M, Bedogni, F, Dudek, D, Hornung, M, Zamorano, J, Omedè, P, Ballocca, F, Barbero, U, Giordana, F, Gili, S, Iannaccone, M, Capodannno, D, Valgimigli, M, Byrne, R, Akagi, T, Carroll, J, Dalvi, B, Ge, J, Kasner, S, Michel-Behnke, I, Pedra, C, Rhodes, J, Søndergaard, L, Thomassen, L & Biondi-Zoccai, GGL 2019, 'European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism', European Heart Journal, vol. 40, no. 38, pp. 3182-3195. https://doi.org/10.1093/eurheartj/ehy649
Pristipino, Christian ; Sievert, Horst ; D'Ascenzo, Fabrizio ; Louis Mas, Jean ; Meier, Bernhard ; Scacciatella, Paolo ; Hildick-Smith, David ; Gaita, Fiorenzo ; Toni, Danilo ; Kyrle, Paul ; Thomson, John ; Derumeaux, Genevieve ; Onorato, Eustaquio ; Sibbing, Dirk ; Germonpré, Peter ; Berti, Sergio ; Chessa, Massimo ; Bedogni, Francesco ; Dudek, Dariusz ; Hornung, Marius ; Zamorano, Jose ; Omedè, Pierluigi ; Ballocca, Flavia ; Barbero, Umberto ; Giordana, Francesca ; Gili, Sebastiano ; Iannaccone, Mario ; Capodannno, Davide ; Valgimigli, Marco ; Byrne, Robert ; Akagi, Teiji ; Carroll, John ; Dalvi, Bharat ; Ge, Junbo ; Kasner, Scott ; Michel-Behnke, Ina ; Pedra, Carlos ; Rhodes, John ; Søndergaard, Lars ; Thomassen, Lars ; Biondi-Zoccai, Giuseppe G.L. / European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. In: European Heart Journal. 2019 ; Vol. 40, No. 38. pp. 3182-3195.
@article{400c75fc80ec4086a75791b720ab3fa0,
title = "European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism",
abstract = "The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number of medical conditions; however, the subject remains controversial and no official statements have been published. This interdisciplinary paper, prepared with involvement of eight European scientific societies, aims to review the available trial evidence and to define the principles needed to guide decision making in patients with PFO. In order to guarantee a strict process, position statements were developed with the use of a modified grading of recommendations assessment, development, and evaluation (GRADE) methodology. A critical qualitative and quantitative evaluation of diagnostic and therapeutic procedures was performed, including assessment of the risk/benefit ratio. The level of evidence and the strength of the position statements of particular management options were weighed and graded according to predefined scales. Despite being based often on limited and non-randomised data, while waiting for more conclusive evidence, it was possible to conclude on a number of position statements regarding a rational general approach to PFO management and to specific considerations regarding left circulation thromboembolism. For some therapeutic aspects, it was possible to express stricter position statements based on randomised trials. This position paper provides the first largely shared, interdisciplinary approach for a rational PFO management based on the best available evidence.",
author = "Christian Pristipino and Horst Sievert and Fabrizio D'Ascenzo and {Louis Mas}, Jean and Bernhard Meier and Paolo Scacciatella and David Hildick-Smith and Fiorenzo Gaita and Danilo Toni and Paul Kyrle and John Thomson and Genevieve Derumeaux and Eustaquio Onorato and Dirk Sibbing and Peter Germonpr{\'e} and Sergio Berti and Massimo Chessa and Francesco Bedogni and Dariusz Dudek and Marius Hornung and Jose Zamorano and Pierluigi Omed{\`e} and Flavia Ballocca and Umberto Barbero and Francesca Giordana and Sebastiano Gili and Mario Iannaccone and Davide Capodannno and Marco Valgimigli and Robert Byrne and Teiji Akagi and John Carroll and Bharat Dalvi and Junbo Ge and Scott Kasner and Ina Michel-Behnke and Carlos Pedra and John Rhodes and Lars S{\o}ndergaard and Lars Thomassen and Biondi-Zoccai, {Giuseppe G.L.}",
year = "2019",
month = "10",
day = "7",
doi = "10.1093/eurheartj/ehy649",
language = "English",
volume = "40",
pages = "3182--3195",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "38",

}

TY - JOUR

T1 - European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

AU - Pristipino, Christian

AU - Sievert, Horst

AU - D'Ascenzo, Fabrizio

AU - Louis Mas, Jean

AU - Meier, Bernhard

AU - Scacciatella, Paolo

AU - Hildick-Smith, David

AU - Gaita, Fiorenzo

AU - Toni, Danilo

AU - Kyrle, Paul

AU - Thomson, John

AU - Derumeaux, Genevieve

AU - Onorato, Eustaquio

AU - Sibbing, Dirk

AU - Germonpré, Peter

AU - Berti, Sergio

AU - Chessa, Massimo

AU - Bedogni, Francesco

AU - Dudek, Dariusz

AU - Hornung, Marius

AU - Zamorano, Jose

AU - Omedè, Pierluigi

AU - Ballocca, Flavia

AU - Barbero, Umberto

AU - Giordana, Francesca

AU - Gili, Sebastiano

AU - Iannaccone, Mario

AU - Capodannno, Davide

AU - Valgimigli, Marco

AU - Byrne, Robert

AU - Akagi, Teiji

AU - Carroll, John

AU - Dalvi, Bharat

AU - Ge, Junbo

AU - Kasner, Scott

AU - Michel-Behnke, Ina

AU - Pedra, Carlos

AU - Rhodes, John

AU - Søndergaard, Lars

AU - Thomassen, Lars

AU - Biondi-Zoccai, Giuseppe G.L.

PY - 2019/10/7

Y1 - 2019/10/7

N2 - The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number of medical conditions; however, the subject remains controversial and no official statements have been published. This interdisciplinary paper, prepared with involvement of eight European scientific societies, aims to review the available trial evidence and to define the principles needed to guide decision making in patients with PFO. In order to guarantee a strict process, position statements were developed with the use of a modified grading of recommendations assessment, development, and evaluation (GRADE) methodology. A critical qualitative and quantitative evaluation of diagnostic and therapeutic procedures was performed, including assessment of the risk/benefit ratio. The level of evidence and the strength of the position statements of particular management options were weighed and graded according to predefined scales. Despite being based often on limited and non-randomised data, while waiting for more conclusive evidence, it was possible to conclude on a number of position statements regarding a rational general approach to PFO management and to specific considerations regarding left circulation thromboembolism. For some therapeutic aspects, it was possible to express stricter position statements based on randomised trials. This position paper provides the first largely shared, interdisciplinary approach for a rational PFO management based on the best available evidence.

AB - The presence of a patent foramen ovale (PFO) is implicated in the pathogenesis of a number of medical conditions; however, the subject remains controversial and no official statements have been published. This interdisciplinary paper, prepared with involvement of eight European scientific societies, aims to review the available trial evidence and to define the principles needed to guide decision making in patients with PFO. In order to guarantee a strict process, position statements were developed with the use of a modified grading of recommendations assessment, development, and evaluation (GRADE) methodology. A critical qualitative and quantitative evaluation of diagnostic and therapeutic procedures was performed, including assessment of the risk/benefit ratio. The level of evidence and the strength of the position statements of particular management options were weighed and graded according to predefined scales. Despite being based often on limited and non-randomised data, while waiting for more conclusive evidence, it was possible to conclude on a number of position statements regarding a rational general approach to PFO management and to specific considerations regarding left circulation thromboembolism. For some therapeutic aspects, it was possible to express stricter position statements based on randomised trials. This position paper provides the first largely shared, interdisciplinary approach for a rational PFO management based on the best available evidence.

UR - http://www.scopus.com/inward/record.url?scp=85072956995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072956995&partnerID=8YFLogxK

U2 - 10.1093/eurheartj/ehy649

DO - 10.1093/eurheartj/ehy649

M3 - Article

C2 - 30141306

AN - SCOPUS:85072956995

VL - 40

SP - 3182

EP - 3195

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 38

ER -